Mersana Therapeutics Inc at Bank of America Global Healthcare Conference Transcript
Hey, everyone. Good morning, and welcome to day 2 of the 2023 BofA Healthcare Conference. Thanks for joining this session with Mersana. My name is Alec Stranahan, I'm Vice President and Senior Biotech Analyst at BofA. And I'm pleased to be joined by Anna Protopapas, President and Chief Executive Officer of Mersana as well as Mohan Bala, Senior Vice President and Strategic Product Planning Program Leadership at Mersana. Thanks for joining, guys.
Well, thanks for having us.
Questions & Answers
Great. So we're just going to jump into Q&A. We've got 15 minutes. But if anyone in the audience has a question, feel free just to raise your hand throughout, and we'll bring you a mic and you can ask your question. But Anna, maybe just to start for those newer to the story, could you give us an
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |